Spearhead Capital Advisors, LLC Biolife Solutions Inc Transaction History

Spearhead Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$10.54 - $24.2 $98,801 - $226,850	-9,374 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$20.81 - $37.29 $38,519 - $69,023	-1,851 Reduced 16.49%	9,374 $213,000
Q4 2021 Jan 25, 2022	BUY	$32.99 - $58.55 $3,694 - $6,557	112 Added 1.01%	11,225 $418,000
Q3 2021 Oct 27, 2021	SELL	$42.03 - $60.5 $1,891 - $2,722	-45 Reduced 0.4%	11,113 $470,000
Q2 2021 Aug 10, 2021	BUY	$29.51 - $44.62 $44,737 - $67,643	1,516 Added 15.72%	11,158 $497,000
Q1 2021 Apr 28, 2021	BUY	$32.95 - $44.24 $317,703 - $426,562	9,642 New	9,642 $347,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.